MOHW to reject additional penal legislation against rebates.

Published: 2005-12-12 06:58:00

Updated: 2005-12-12 06:58:00

In the inquiry raised by the Korea Independent Commission against Corruption (KICAC) over the improvement of irregular drug trade practices, the MOHW responded to reject other additional legislation of penalizing the rebate practices in the Pharmaceutical Affairs Act than the Criminal Act or the ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK